Sproxil gains $1.8 million in new funding

Categories: Latest News.

Official announcement Tuesday morning US Eastern Time of what we picked up from VentureFizz and SecuringPharma back on 14 MarSproxil’s now-disclosed investor is Acumen Fund, a nonprofit global venture fund focusing on poverty in South Asia and East Africa. Their $1.8 million investment in Sproxil will enable a buildout of its sales teams in the U.S. and Nigeria, expansion into India and Kenya, and to fund further improvements to their technology. Press release.